Pandemic Strategies to Boost Trial Enrollment Should Stay
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Although enrollment into lung cancer clinical
Read moreEditor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Although enrollment into lung cancer clinical
Read moreBEIJING (Reuters) – Chinese researchers are testing the mixing of COVID-19 vaccine doses developed by CanSino Biologics and a unit
Read moreClinicians should be on the lookout for immune-related adverse reactions (irAEs) even after patients have been receiving anti–programmed cell death
Read moreSAO PAULO (Reuters) – Brazilian health regulator Anvisa approved on Thursday the beginning of clinical trials in the country for
Read moreBEIJING (Reuters) – China’s CanSino Biologics Inc said the efficacy rate for its single-dose COVID-19 vaccine may fall over time
Read moreEditor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A coronavirus vaccine that could be
Read morePatients with hypothyroidism treated with the three most common pharmacological strategies of levothyroxine (LT4) alone, LT4 in combination with triiodothyronine
Read moreThe STAR total ankle replacement breaks at a higher rate than similar devices do, and surgeons should closely monitor patients
Read moreAtopic dermatitis (AD) is associated with lower patient satisfaction scores in adults, suggesting there are unmet needs in clinical AD
Read moreEditor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Health Canada, the country’s health regulatory
Read more